Skip to main content
. 2016 Mar 30;31(3):479–487. doi: 10.3904/kjim.2015.253

Table 1.

Demographic, clinical, biochemical, and ultrasonic characteristics of patients

Characteristic ALD (n = 86) NAFLD (n = 53) t/Z/X2 p value
Demographic
 Sex, male:female 85:1 37:16 25.74 < 0.001
 Age, yr 49.47 ± 10.31 39.58 ± 14.37 –4.710 < 0.001
Clinical
 BMI, kg/m2 23.60 ± 3.59 26.17 (3.90) –4.352 < 0.001
 WC, cm 89.62 ± 9.56 93.68 ± 10.68 1.978 0.026
 SBP, mmHg 121.36 ± 10.32 123.76 ± 11.67 1.977 0.208
 DBP, mmHg 79.69 ± 8.64 82.48 ± 9.06 1.304 0.072
Biochemical
 LDL-C, mmol/L 2.87 ± 1.28 2.92 (0.86) –0.410 0.682
 TG, mmol/L 1.92 (1.74) 1.78 (1.21) –1.003 0.316
 TC, mmol/L 5.14 (2.80) 4.80 ± 1.18 0.961 0.336
 FBG, mmol/L 6.02 (1.75) 5.63 (0.96) 0.676 0.499
 AST/ALT 1.66 (1.24) 0.52 (0.23) –6.487 < 0.001
 MCV, fl 98.84 ± 8.64 89.60 (6.40) –6.249 < 0.001
 GGT, IU/L 245.0 (602.50) 58.0 (41.60) –6.225 < 0.001
Ultrasonography
 Accuracy, % 78 (90.68) 50 (94.34) 0.597 0.440
FibroScan parameter
 CAP, dB/m 242.87 ± 28.15 254.23 ± 50.46 1.98 0.091

Values are presented as mean ± SD or median (4th percentile interval).

ALD, alcoholic liver disease; NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; TC, total cholesterol; FBG, fasting blood glucose; AST/ALT, alanine aminotransferase/aspartate aminotransferase; MCV, mean corpuscular volume; GGT, γ-glutamyl transpeptidase; CAP, controlled attenuation parameter.